Literature DB >> 30603829

Shallow nasal RAE tube depth after head and neck surgery: association with preoperative and intraoperative factors.

Ha Yeon Kim1, Eung Jin Kim2, Cheung Soo Shin2, Jeongmin Kim3.   

Abstract

PURPOSE: To evaluate risk factors associated with improper postoperative nasal Ring-Adair-Elwyn (RAE) tube depth.
METHODS: We retrospectively enrolled 133 adult patients who were admitted to the intensive care unit (ICU) with the nasal RAE tube after head and neck surgery. Postoperative chest radiography was performed to confirm nasal RAE tube depth immediately after the patient was admitted to the ICU. Proper tube depth was defined as the tube tip between 2 and 7 cm above the carina. The patients were divided into the proper-depth group (78 patients) and the improper-depth group (55 patients). Patients' characteristics were collected. The risk factors for improper postoperative tube depth were assessed using logistic regression analysis. MAIN
RESULTS: All patients who showed improper tube depth had a shallow tube depth (the tube tip > 7 cm above the carina). Multivariable analysis revealed that tall stature [odds ratio (OR) 1.16; 95% confidence interval (CI) 1.08-1.25; P < 0.001], prolonged anesthesia duration (OR 1.16; 95% CI 1.02-1.32; P = 0.026), and right-sided surgical field as compared to the left (OR 0.36; 95% CI 0.14-0.93; P = 0.034) or median field (OR 0.25; 95% CI 0.07-0.85; P = 0.027) were risk factors associated with postoperative shallow tube depth.
CONCLUSIONS: Tall stature, prolonged anesthesia duration, and right-sided surgical field were independent risk factors for postoperative shallow nasal RAE tube depth.

Entities:  

Keywords:  Depth; Nasal intubation; Postoperative care; Risk factor; Shallow

Mesh:

Year:  2019        PMID: 30603829     DOI: 10.1007/s00540-018-2595-4

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  1 in total

1.  Optimal placement of nasal RAE tube.

Authors:  Jin-Hua Jin; Fu-Shan Xue; Yu-Hui Wang
Journal:  J Anesth       Date:  2019-03-09       Impact factor: 2.078

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.